TY - BOOK AU - Ferlay, J. S. I. AU - Ervik, M. AU - Dikshit, R. AU - Eser, S. AU - Mathers, C. AU - Rebelo PY - 2013 DA - 2013// TI - GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 PB - International Agency for Research on Cancer CY - Lyon ID - Ferlay2013 ER - TY - JOUR AU - Siegel, R. AU - Naishadham, D. AU - Jemal, A. PY - 2013 DA - 2013// TI - Cancer statistics, 2013 JO - CA Cancer J Clin VL - 63 UR - https://doi.org/10.3322/caac.21166 DO - 10.3322/caac.21166 ID - Siegel2013 ER - TY - STD TI - Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018; ID - ref3 ER - TY - JOUR AU - Bast, R. C. AU - Hennessy, B. AU - Mills, G. B. PY - 2009 DA - 2009// TI - The biology of ovarian cancer: new opportunities for translation JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2644 DO - 10.1038/nrc2644 ID - Bast2009 ER - TY - JOUR AU - Desmeules, P. AU - Trudel, D. AU - Turcotte, S. AU - Sirois, J. AU - Plante, M. AU - Gregoire, J. PY - 2015 DA - 2015// TI - Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis JO - Hum Pathol VL - 46 UR - https://doi.org/10.1016/j.humpath.2015.01.014 DO - 10.1016/j.humpath.2015.01.014 ID - Desmeules2015 ER - TY - JOUR AU - Trudel, D. AU - Desmeules, P. AU - Turcotte, S. AU - Plante, M. AU - Gregoire, J. AU - Renaud, M. C. PY - 2014 DA - 2014// TI - Visual and automated assessment of matrix metalloproteinase-14 tissue expression for the evaluation of ovarian cancer prognosis JO - Mod Pathol VL - 27 UR - https://doi.org/10.1038/modpathol.2014.32 DO - 10.1038/modpathol.2014.32 ID - Trudel2014 ER - TY - JOUR AU - Perigny, M. AU - Bairati, I. AU - Harvey, I. AU - Beauchemin, M. AU - Harel, F. AU - Plante, M. AU - Tetu, B. PY - 2008 DA - 2008// TI - Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer JO - Am J Clin Pathol VL - 129 UR - https://doi.org/10.1309/49LA9XCBGWJ8F2KM DO - 10.1309/49LA9XCBGWJ8F2KM ID - Perigny2008 ER - TY - JOUR AU - De Luca, A. AU - De Falco, M. AU - Severino, A. AU - Campioni, M. AU - Santini, D. AU - Baldi, F. PY - 2003 DA - 2003// TI - Distribution of the serine protease HtrA1 in normal human tissues JO - J Histochem Cytochem VL - 51 UR - https://doi.org/10.1177/002215540305101004 DO - 10.1177/002215540305101004 ID - De Luca2003 ER - TY - JOUR AU - He, X. AU - Ota, T. AU - Liu, P. AU - Su, C. AU - Chien, J. AU - Shridhar, V. PY - 2010 DA - 2010// TI - Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-3557 DO - 10.1158/0008-5472.CAN-09-3557 ID - He2010 ER - TY - JOUR AU - Chien, J. AU - Staub, J. AU - Hu, S. I. AU - Erickson-Johnson, M. R. AU - Couch, F. J. AU - Smith, D. I. PY - 2004 DA - 2004// TI - A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1207271 DO - 10.1038/sj.onc.1207271 ID - Chien2004 ER - TY - JOUR AU - Chien, J. AU - Ota, T. AU - Aletti, G. AU - Shridhar, R. AU - Boccellino, M. AU - Quagliuolo, L. PY - 2009 DA - 2009// TI - Serine protease HtrA1 associates with microtubules and inhibits cell migration JO - Mol Cell Biol VL - 29 UR - https://doi.org/10.1128/MCB.00035-09 DO - 10.1128/MCB.00035-09 ID - Chien2009 ER - TY - JOUR AU - Shridhar, V. AU - Sen, A. AU - Chien, J. AU - Staub, J. AU - Avula, R. AU - Kovats, S. PY - 2002 DA - 2002// TI - Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization JO - Cancer Res VL - 62 ID - Shridhar2002 ER - TY - JOUR AU - Narkiewicz, J. AU - Klasa-Mazurkiewicz, D. AU - Zurawa-Janicka, D. AU - Skorko-Glonek, J. AU - Emerich, J. AU - Lipinska, B. PY - 2008 DA - 2008// TI - Changes in mRNA and protein levels of human HtrA1, HtrA2 and HtrA3 in ovarian cancer JO - Clin Biochem VL - 41 UR - https://doi.org/10.1016/j.clinbiochem.2008.01.004 DO - 10.1016/j.clinbiochem.2008.01.004 ID - Narkiewicz2008 ER - TY - JOUR AU - Chien, J. AU - Aletti, G. AU - Baldi, A. AU - Catalano, V. AU - Muretto, P. AU - Keeney, G. L. PY - 2006 DA - 2006// TI - Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity JO - J Clin Invest VL - 116 UR - https://doi.org/10.1172/JCI27698 DO - 10.1172/JCI27698 ID - Chien2006 ER - TY - JOUR AU - He, X. AU - Khurana, A. AU - Maguire, J. L. AU - Chien, J. AU - Shridhar, V. PY - 2012 DA - 2012// TI - HtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation JO - Int J Cancer VL - 130 UR - https://doi.org/10.1002/ijc.26044 DO - 10.1002/ijc.26044 ID - He2012 ER - TY - JOUR AU - Catalano, V. AU - Mellone, P. AU - d'Avino, A. AU - Shridhar, V. AU - Staccioli, M. P. AU - Graziano, F. PY - 2011 DA - 2011// TI - HtrA1, a potential predictor of response to cisplatin-based combination chemotherapy in gastric cancer JO - Histopathology VL - 58 UR - https://doi.org/10.1111/j.1365-2559.2011.03818.x DO - 10.1111/j.1365-2559.2011.03818.x ID - Catalano2011 ER - TY - JOUR AU - Lehner, A. AU - Magdolen, V. AU - Schuster, T. AU - Kotzsch, M. AU - Kiechle, M. AU - Meindl, A. PY - 2013 DA - 2013// TI - Downregulation of serine protease HTRA1 is associated with poor survival in breast cancer JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0060359 DO - 10.1371/journal.pone.0060359 ID - Lehner2013 ER - TY - JOUR AU - Zhu, F. AU - Jin, L. AU - Luo, T. P. AU - Luo, G. H. AU - Tan, Y. AU - Qin, X. H. PY - 2010 DA - 2010// TI - Serine protease HtrA1 expression in human hepatocellular carcinoma JO - Hepatobiliary Pancreat Dis Int VL - 9 ID - Zhu2010 ER - TY - JOUR AU - du Bois, A. AU - Quinn, M. AU - Thigpen, T. AU - Vermorken, J. AU - Avall-Lundqvist, E. AU - Bookman, M. PY - 2005 DA - 2005// TI - Gynecologic Cancer I, AGO O, ANZGOG, EORTC, GEICO, GINECO, GOG, JGOG, MRC/NCRI, NCIC CTG, NCI US, NSGO, RTOG, SGCTG, IGCS, Organizational team of the two prior International O. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004) JO - Ann Oncol VL - 16 Suppl 8 ID - du Bois2005 ER - TY - JOUR AU - Stuart, G. C. AU - Kitchener, H. AU - Bacon, M. AU - duBois, A. AU - Friedlander, M. AU - Ledermann, J. PY - 2011 DA - 2011// TI - Participants of 4th Ovarian cancer Consensus C, Gynecologic Cancer I. 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference JO - Int J Gynecol Cancer VL - 21 UR - https://doi.org/10.1097/IGC.0b013e31821b2568 DO - 10.1097/IGC.0b013e31821b2568 ID - Stuart2011 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. AU - Schwartz, L. H. AU - Sargent, D. AU - Ford, R. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - JOUR AU - Rustin, G. J. AU - Vergote, I. AU - Eisenhauer, E. AU - Pujade-Lauraine, E. AU - Quinn, M. AU - Thigpen, T. PY - 2011 DA - 2011// TI - Gynecological Cancer I. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG) JO - Int J Gynecol Cancer VL - 21 UR - https://doi.org/10.1097/IGC.0b013e3182070f17 DO - 10.1097/IGC.0b013e3182070f17 ID - Rustin2011 ER - TY - JOUR AU - Benoit, M. H. AU - Hudson, T. J. AU - Maire, G. AU - Squire, J. A. AU - Arcand, S. L. AU - Provencher, D. PY - 2007 DA - 2007// TI - Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines JO - Int J Oncol VL - 30 ID - Benoit2007 ER - TY - JOUR AU - Ouellet, V. AU - Zietarska, M. AU - Portelance, L. AU - Lafontaine, J. AU - Madore, J. AU - Puiffe, M. L. PY - 2008 DA - 2008// TI - Characterization of three new serous epithelial ovarian cancer cell lines JO - BMC Cancer VL - 8 UR - https://doi.org/10.1186/1471-2407-8-152 DO - 10.1186/1471-2407-8-152 ID - Ouellet2008 ER - TY - JOUR AU - Clawson, G. A. AU - Bui, V. AU - Xin, P. AU - Wang, N. AU - Pan, W. PY - 2008 DA - 2008// TI - Intracellular localization of the tumor suppressor HtrA1/Prss11 and its association with HPV16 E6 and E7 proteins JO - J Cell Biochem VL - 105 UR - https://doi.org/10.1002/jcb.21804 DO - 10.1002/jcb.21804 ID - Clawson2008 ER - TY - JOUR AU - Lorenzi, T. AU - Lorenzi, M. AU - Altobelli, E. AU - Marzioni, D. AU - Mensa, E. AU - Quaranta, A. PY - 2013 DA - 2013// TI - HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker JO - Int J Cancer VL - 133 ID - Lorenzi2013 ER - TY - JOUR AU - Sood, A. K. AU - Fletcher, M. S. AU - Gruman, L. M. AU - Coffin, J. E. AU - Jabbari, S. AU - Khalkhali-Ellis, Z. PY - 2002 DA - 2002// TI - The paradoxical expression of maspin in ovarian carcinoma JO - Clin Cancer Res VL - 8 ID - Sood2002 ER - TY - JOUR AU - Baldi, A. AU - Mottolese, M. AU - Vincenzi, B. AU - Campioni, M. AU - Mellone, P. AU - Di Marino, M. PY - 2008 DA - 2008// TI - The serine protease HtrA1 is a novel prognostic factor for human mesothelioma JO - Pharmacogenomics VL - 9 UR - https://doi.org/10.2217/14622416.9.8.1069 DO - 10.2217/14622416.9.8.1069 ID - Baldi2008 ER - TY - JOUR AU - Guadamillas, M. C. AU - Cerezo, A. AU - Del Pozo, M. A. PY - 2011 DA - 2011// TI - Overcoming anoikis--pathways to anchorage-independent growth in cancer JO - J Cell Sci VL - 124 UR - https://doi.org/10.1242/jcs.072165 DO - 10.1242/jcs.072165 ID - Guadamillas2011 ER - TY - JOUR AU - Hajra, K. M. AU - Tan, L. AU - Liu, J. R. PY - 2008 DA - 2008// TI - Defective apoptosis underlies chemoresistance in ovarian cancer JO - Adv Exp Med Biol VL - 622 UR - https://doi.org/10.1007/978-0-387-68969-2_16 DO - 10.1007/978-0-387-68969-2_16 ID - Hajra2008 ER - TY - JOUR AU - Campioni, M. AU - Severino, A. AU - Manente, L. AU - Tuduce, I. L. AU - Toldo, S. AU - Caraglia, M. PY - 2010 DA - 2010// TI - The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 protein JO - Mol Cancer Res VL - 8 UR - https://doi.org/10.1158/1541-7786.MCR-09-0473 DO - 10.1158/1541-7786.MCR-09-0473 ID - Campioni2010 ER -